IGF1 and neoplasm: Insulin-like growth factor (IGF) axis is one of the most investigated targets in cancer research due to the overexpression of its receptor in several types of human cancer including PC, and targeting IGF axis showed promising anti-tumor capabilities in preclinical studies [20].